F-fluorocholine PET/CT is commonly used for staging and assessing treatment response in prostate cancer patients. Growing clinical experience has shown that F-fluorocholine can actually accumulate in sites of inflammation. We report a rare case of a prostate cancer patient with incidentally detected Peyronie disease.
No takes yet. Share an insight, caveat, or question.
Cegła et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: